This Part of the Cannabis Market Has Been Overlooked

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.

Subscribe to receive our free weekly newsletter in your inbox each Sunday morning.


The cannabis sector has been rallying like crazy! It is now up year-to-date but slightly behind the S&P 500’s gain of 15.9%. The NCV Global Cannabis Sector Index has gained 14.4% in 2023 thus far, though it is still down from where it was a year ago:

The driver of the investor interest has been the potential move of cannabis to a Schedule 3 drug, which could help achieve a majorly positive ending of the 280E taxation. We discussed this two weeks ago, suggesting that cannabis stocks may be escaping from hell. Last week, we warned that the MSOs have gotten riskier, as the prices have risen substantially and the DEA move is not a done deal. This week, the rally was aided by news that the Senate will be voting on SAFE Banking.

A part of the market that is still down year-to-date and that hasn’t bounced significantly is the Real Estate Investment Trusts (REITs). There are four that I track, and here is their performance in 2023:

Innovative Industrial Properties was the first REIT to go public, and it trades on the NYSE. AFC Gamma and Chicago Atlantic are more recent additions to the market and trade on the NASDAQ. They are both mortgage REITs with very high dividend yields. NewLake Capital appears very cheap, but it trades on the OTC, which limits a number of investors from owning it. It is an equity REIT, like IIPR.

These stocks seem cheap. I include Chicago Atlantic in my model portfolio at 420 Investor after buying it this week, and it trades near tangible book value. NewLake trades considerably below tangible book value. Investors have been concerned that tenants could quit paying rent or making payments on their mortgages.

We concluded two weeks ago that if 280E goes away, it could be very positive for ancillaries, like these REITs, though they don’t pay the tax. Our view is that their customers will benefit, and investors will find them less risky with better customers. Chasing MSOs may work out, but it may not as well. It seems safer to buy what hasn’t really rallied much, the REITs.

Like this newsletter? Sign up, and you will receive a free copy by email each Sunday morning. Each week, we share the top stories and write an original perspective as well.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:


Michigan Cannabis Sales Stall in August

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer the Canadian Cannabis LP Index, the American Cannabis Operator Index and the Ancillary Cannabis Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.


Alan & Joel

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter